Cellcept

Links shared publicly online about this topic

FDA Alert: CellCept (mycophenolate mofetil)

drugs.com — “FDA Alert: CellCept (mycophenolate mofetil)View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on February 12, 2009 at 11:16 pm By:

drugscom Drugs.com Health Site

FDA Alert - CellCept (mycophenolate mofetil) - http://tinyurl.com/ak4j9m

3 years ago...

CELLCEPT CAPSULES (Mycophenolate mofetil) drug information from MPR

empr.com — “CELLCEPT CAPSULES (Mycophenolate mofetil) drug information for Immunomodulators from MPR including side effects, drug interactions, dosing, contraindications and precautions.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 8, 2009 at 5:24 am By:

eMPR MPR Medical Publisher

MPR News: CELLCEPT CAPSULES: Monograph added. http://tinyurl.com/knvxlt

3 years ago...

CELLCEPT CAPSULES (Mycophenolate mofetil) drug information from MPR

empr.com — “CELLCEPT CAPSULES (Mycophenolate mofetil) drug information for Immunomodulators from MPR including side effects, drug interactions, dosing, contraindications and precautions.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on December 2, 2009 at 5:17 am By:

eMPR MPR Medical Publisher

MPR News: CELLCEPT CAPSULES: Adverse reactions: added pure red cell aplasia (w. concomitant immunosuppressants). http://bit.ly/5VJuM9

2 years ago...

FDA Alert: CellCept (mycophenolate mofetil) August 2009

drugs.com — “FDA Alert: CellCept (mycophenolate mofetil) August 2009View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 15, 2009 at 2:40 am By:

drugscom Drugs.com Health Site

FDA Alert - FDA Warns of Pure Red Cell Aplasia (PRCA) in CellCept Patients - http://bit.ly/OOw43

2 years ago...

Cellcept For Multiple Sclerosis (Newest posts first) - The People's Medicine Community

prescriptiondrug-info.com — “cellcept was prescribed for me by neurologist for multiple sclerosis Have had MS for 20 years and had symptom progression 2 years ago Within 4 weeks I had almost complete turnaround with my MS disabilities I could see better was able to walk without my cane I could swallow without choking I speach a (Newest posts first)View full resource at prescriptiondrug-info.com

  • View Related
  • Share

Most Recently Shared on January 18, 2011 at 3:35 am By:

druginfo Medicine Community Support

" i AM SO SCARED ! my dr prescribed to me friday. was on copaxone for 2 yrs then went to betaseron that didnt http://PD0.US/F185442

1 year ago...

Lupus Foundation Of America Says Results Of Latest Study Of CellCept Provide Encouragement And Hope For People With Lupus Nephritis

medicalnewstoday.com — “The Lupus Foundation of America praised the results of a new long-term study for the treatment of lupus nephritis (lupus-related kidney disease) which demonstrated superiority of CellCept® (myView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 6, 2010 at 11:06 am By:

LupusLine Health Line Health Site

Lupus Foundation Of America Says Results Of Latest Study Of CellCept Provide Encouragement And Hope For People Wi... http://w.sns.ly/H0G48

2 years ago...

Lupus Research Institute Hails Results of CellCept Trial in People with Lupus Kidney Disease - PR.com

pr.com — “Lupus Research Institute Hails Results of CellCept Trial in People with Lupus Kidney Disease - on PR.comView full resource at pr.com

  • View Related
  • Share

Most Recently Shared on June 5, 2010 at 9:00 am By:

PRcomMedical PR.com Health News Feed

Lupus Research Institute Hails Results of CellCept® Trial in People with Lupus Kidney Disease http://bit.ly/aVk7mb

2 years ago...

Clinical Trial: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis - Renal and Urology News

renalandurologynews.com — “A look at the following clinical trial: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus NephritisView full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on March 12, 2010 at 6:11 pm By:

renalandurology Renal Urology News Health News, Nephrology, Urology, and Medical Publisher

Clinical Trial: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis: A look... http://bit.ly/8YZmgF

2 years ago...

#physicians Does Cellcept decrease the CD4 lymphocyte count? #diagnosis #healthcare #clinical #hcsm

app.sermo.com — “#physicians Does Cellcept decrease the CD4 lymphocyte count? #diagnosis #healthcare #clinical #hcsmView full resource at app.sermo.com

  • View Related
  • Share

Most Recently Shared on April 29, 2011 at 3:49 pm By:

ACR: Azathioprine Bests CellCept for Vasculitis (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “ATLANTA (MedPage Today) -- Azathioprine was more effective than mycophenolate mofetil (CellCept) in preventing relapse in patients with ANCA-positive vasculitis, an open-label randomized trial found.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 10:18 pm By:

MedicalFeed MedicalFeed Health News Feed

ACR: Azathioprine Bests CellCept for Vasculitis (CME/CE): ATLANTA (MedPage Today) -- Azathioprine was more effecti... http://bit.ly/azyc4I

1 year ago...

FDA warns of pure red cell aplasia (PRCA) with CellCept - MPR

empr.com — “The FDA and Roche have notified healthcare professionals that cases of pure red cell aplasia (PRCA), a type of anemia in which there is a selective reduction of red blood cell precursors on bone marrow examination, have been reported in patients treated with CellCept (mycophenolate mofetil).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 14, 2009 at 5:41 pm By:

eMPR MPR Medical Publisher

MPR News: FDA warns of pure red cell aplasia (PRCA) with CellCept: The FDA and Roche have notified heal.. http://bit.ly/EIAU8

2 years ago...

CellCept Has Positive Results in Phase III Lupus Nephritis Trial | Lupus Research Institute

lupusresearchinstitute.org — “The Lupus Research Institute (LRI) provides LupusResearchInstitute.org to help scientists and physicians, patients, and their families champion novel and innovative lupus research. On the homepage you will find information about lupus and the LRI as well as lupus research and news.View full resource at lupusresearchinstitute.org

  • View Related
  • Share

Most Recently Shared on June 3, 2010 at 7:59 pm By:

LupusResearch LRI Health Organization

CellCept® Has Positive Results in Phase III Lupus Nephritis Trial - Read more at http://ht.ly/1TL8g

2 years ago...

Galenica.com - CellCept reaches positive results in Phase III trial in Lupus Nephritis

galenica.com — “Vifor Pharma, the pharma business sector of the Galenica Group, and Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the maintenance phase of the Aspreva Lupus Man-agement Study (ALMS) has successfully achieved its primary endpoint. The trial demonstrates the superiority of Roche's CellCept (mycophenolate mofetil) versus azathioprine (AZA) in de-laying treatment failure in patients with Lupus Nephritis (LN). ALMS is one of the largest stud-ies ever conducted in LN.View full resource at galenica.com

  • View Related
  • Share

Most Recently Shared on September 22, 2010 at 4:12 pm By:

LupusMD Lupus Doctor Internist, Rheumatologist, Physician, and Doctor

ALMSTrialCellCept vs AZA rx in patients who responded to CYT or AZA inductionMMF superior to AZA in delaying rx failure http://bit.ly/9f1pD0

1 year ago...

CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (MMF) - Renal and Urology News

renalandurologynews.com — “A look at the following clinical trial: CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (MMF)View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on July 14, 2011 at 8:23 pm By:

renalandurology Renal Urology News Health News, Nephrology, Urology, and Medical Publisher

CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (MMF): A look at the ... http://bit.ly/pTKg1h

7 months ago...

Medical News: FDA Strengthens Warning on Transplant Drug - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- A warning of a risk of pure red cell aplasia (PRCA) has been added to the label and prescribing information for mycophenolate mofetil (CellCept).View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 15, 2009 at 3:33 am By:

MedicalNews Medical News Health News

FDA Strengthens Warning on Transplant Drug http://ow.ly/15L6sz

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • eMPR

    MPR

    eMPR.com provides up-to-date, concise drug information at the point-of-care.

    View Profile

  • eMPR

    MPR

    eMPR.com provides up-to-date, concise drug information at the point-of-care.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390